Updated On: 28 April, 2021 06:23 PM IST | Pune | mid-day online correspondent
This follows widespread criticism of its pricing policy as it had sold the initial doses of Covishield to the central government at Rs 150 per dose.

File Pic
Serum Institute of India’s CEO, Adar Poonawalla, on Wednesday, announced that Covishield’s price for states will be slashed from Rs 400 to Rs 300 as a philanthropic gesture.
As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from Rs.400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives.